Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis.
about
ECHS1 interacts with STAT3 and negatively regulates STAT3 signalingMitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics ApproachPeroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effectBioinformatics-driven identification and examination of candidate genes for non-alcoholic fatty liver disease.Differential expression of liver proteins between obesity-prone and obesity-resistant rats in response to a high-fat diet.Ananas comosus L. Leaf Phenols and p-Coumaric Acid Regulate Liver Fat Metabolism by Upregulating CPT-1 Expression.Bioinformatics analysis of proteomic profiles during the process of anti-Thy1 nephritisMitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice.Proteomic analysis of liver mitochondria from rats with nonalcoholic steatohepatitisMolecular mechanism of acute radiation enteritis revealed using proteomics and biological signaling network analysis in rats.PDIA3 Knockdown Exacerbates Free Fatty Acid-Induced Hepatocyte Steatosis and Apoptosis.Identification of protein targets of reactive metabolites of tienilic acid in human hepatocytes.Reduced mitochondrial mass and function add to age-related susceptibility toward diet-induced fatty liver in C57BL/6J mice.Differential representation of liver proteins in obese human subjects suggests novel biomarkers and promising targets for drug development in obesity.Tanshinone IIA ameliorates dextran sulfate sodium-induced inflammatory bowel disease via the pregnane X receptor.Mitochondrial Protein Profile in Mice with Low or Excessive Selenium DietsSuppression of fat deposition in broiler chickens by (-)-hydroxycitric acid supplementation: A proteomics perspective.Mitochondrial-related proteomic changes during obesity and fasting in mice are greater in the liver than skeletal muscles.IRS2 and PTP1B: Two opposite modulators of hepatic insulin signalling.Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact.Small hepatitis B surface antigen interacts with and modulates enoyl-coenzyme A hydratase expression in hepatoma cells.Genomics and proteomics in liver fibrosis and cirrhosis.Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients.Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats.Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease.Early changes in the liver-soluble proteome from mice fed a nonalcoholic steatohepatitis inducing diet.Comparative proteomic analysis using 2DE-LC-MS/MS reveals the mechanism of Fuzhuan brick tea extract against hepatic fat accumulation in rats with nonalcoholic fatty liver disease.Role of adenosine 5'-monophosphate-activated protein kinase in α-linolenic acid-induced intestinal lipid metabolism.
P2860
Q24317798-52986A5A-AD49-4C36-B53A-199A71FEE519Q26753043-E7A8E24F-6F14-4342-863A-981A1B0E3FF2Q33753420-1C847224-9B79-47D9-B55A-50D3A223B352Q33826084-CACFA064-A657-4AB0-A03C-B2BBDE98594BQ33887597-24A1410E-181E-4D99-8D95-2F0BB1610C68Q34093727-4169135B-120A-4B5C-8142-6800BA995FFEQ34096857-F19419F1-09AC-4CA4-951C-33A129524ACCQ35115065-BCACACEE-C946-480C-BACB-9AF649CC6904Q35159970-162027F0-1622-4B75-A77E-13C344DB9214Q35187919-C5052423-2EED-4D08-B271-67C34691A9BCQ35716234-72E8012A-364C-43FC-BDE8-2CC3F7150D14Q35981110-A59C9C1B-98EB-44F3-8105-B895C7D18BBEQ36150744-A1F33871-2C82-48D7-99AD-E8021BA1984FQ36301141-99C8F430-ABC6-4FCD-91D5-C6FA407D174DQ36365170-C8D2417C-7A73-4A09-B37C-392EB9E5E20FQ37134657-B3142FA3-4CA3-460E-90E6-17100A06B4EDQ37227726-0B8069EE-C43B-44BD-A826-04ACC8B104E8Q37670352-4CFB8DAC-ED9D-441D-92B5-71E8888DB455Q37852704-7B6DB0B6-F9F0-4E09-8EB7-B3FE648428EDQ38538187-891FAC3D-579D-411E-AF8A-433DF2C12B87Q39218861-D43B51E0-194C-43B5-8A84-C7BD31C3ACA6Q40462698-7833DFE7-9C57-4F1E-AD63-4742D3D1EB92Q41636426-F0889C0B-23BA-4652-AE93-47A67186D7C6Q42607892-0C9BC344-836F-4E4F-9AAC-154B9F3E5369Q48171433-86DC7F6A-8C61-4078-9EF6-B6712ABBE9C2Q51339526-8D047EE7-DAD3-465F-A141-BF0F46F05EDCQ51625813-3AD1946B-64CA-4534-9B25-9C015EA7898DQ54253077-0A434D99-F073-4BE2-A497-4BAD93C74DFD
P2860
Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Functional proteomic analysis ...... exacerbates hepatic steatosis.
@ast
Functional proteomic analysis ...... exacerbates hepatic steatosis.
@en
Functional proteomic analysis ...... exacerbates hepatic steatosis.
@nl
type
label
Functional proteomic analysis ...... exacerbates hepatic steatosis.
@ast
Functional proteomic analysis ...... exacerbates hepatic steatosis.
@en
Functional proteomic analysis ...... exacerbates hepatic steatosis.
@nl
prefLabel
Functional proteomic analysis ...... exacerbates hepatic steatosis.
@ast
Functional proteomic analysis ...... exacerbates hepatic steatosis.
@en
Functional proteomic analysis ...... exacerbates hepatic steatosis.
@nl
P2093
P2860
P356
P1433
P1476
Functional proteomic analysis ...... exacerbates hepatic steatosis.
@en
P2093
Chaohui Yu
Chengfu Xu
Hangdong Wei
Juntao Yang
Songfeng Wu
Xiaohong Qian
P2860
P304
P356
10.1002/HEP.23486
P407
P577
2010-04-01T00:00:00Z